Colorectal Cancer Prevention Screening

Facts:

  • Combined data from the 2004 and 2006 New Mexico Behavioral Risk Factor Surveillance System (BRFSS) surverys showed that 53.1% of New Mexican respondents were considered currently screened based on having had either FOBT within the previous year and/or a lower endoscopy within the previous ten years. 
  • Colorectal cancer is the 4th most frequently diagnosed cancer in NM and is the 2nd leading cause of cancer death.
  • Clinical studies have suggested that many of these deaths and new cases may be preventable with appropriate cancer screening.
  • Screening detects early-stage cancers, which can be very curable with surgery, and pre-cancerous polyps, which can be removed by colonoscopy or surgery.
  • Just over half of the colorectal cancers diagnosed in NM are found at an advanced stage - when these cancers are less curable.

Goal:

  • To increase colorectal screening across New Mexico for ages 50 and up using any of the following tests: Fecal Occult Blood Testing (FOBT), Flexible Sigmoidoscopy, Dual Contrast Barium Enema (DCBE) or Colonoscopy.

CPI Intervention:

  • The workgroup created a handbook for health care providers which has information on colorectal cancer epidemiology, screening, treatment, prognosis, resources, and reimbursement issues. The handbook is accredited for a maximum of 4 credit hours of continuing medical education. The third edition was published in June, 2008.
  • The workgroup surveyed providers to assess endoscopic screening capacity statewide. The analysis was presented at the Digestive Disease Week Conference in Florida, May 2003 and was published as an article in the January 2005 edition of the CDC online journal "Preventing Chronic Disease: Public Health Research, Practice and Policy."
  • The workgroup collaborated with the Arizona Cancer Center to convene the second New Mexico-Arizona summit on Colorectal Cancer Screening Capacity Building, Dialogue for Action II, June 16-17, 2005 in Tempe, AZ.
  • House Joint Memorial 74 requested the Department of Health to create a task force to investigate the issues concerning insurance coverage for and access to screening and detection for colorectal cancer. Several members of the CPI Colorectal Cancer workgroup participated on this task force which reported to the appropriate interim committee of the legislature in October 2003.

Resources:

Committee Chair: Richard Hoffman MD, MPH rhoffman@unm.edu 

CPI

Copyright © 2005 New Mexico Medical Society